Quantcast

Latest Denosumab Stories

2009-12-10 12:30:00

SAN ANTONIO, Dec. 10 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced further detailed results from a Phase 3, head-to-head trial of denosumab versus Zometa® (zoledronic acid) in the treatment of bone metastases in 2,046 patients with advanced breast cancer.

2009-12-10 12:30:00

An estimated 70 to 80 percent of patients with advanced or stage four breast cancer develop bone metastases. Bone metastases occurs when the disease progresses to a patient's bones.

2009-11-23 14:05:00

THOUSAND OAKS, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) was honored with two 2009 Scrip Awards, winning for Best Overall Pipeline and for Best New Drug for Nplate® (romiplostim), at a Nov. 18 ceremony in London.

2009-10-19 07:00:00

THOUSAND OAKS, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced that the U.S.

2009-08-14 11:07:47

Amgen's bone drug, denosumab, has been partially endorsed by an advisory committee to the U.S.

2009-08-13 17:37:00

THOUSAND OAKS, Calif., Aug. 13 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) issued the following statement on the outcome of today's meeting with the U.S.

2009-08-13 06:52:00

THOUSAND OAKS, Calif., Aug. 13 /PRNewswire-FirstCall/ -- Amgen Inc.


Word of the Day
chauffeuse
  • A woman chauffeur.
  • A woman who operates an automobile.
The word 'chaffeuse' comes from French, and is the feminine form of 'chauffeur'.
Related